Key result
Enalapril reduced cardiomegaly in rats with chronic myocardial infarction, whereas salt restriction had no effect on cardiac weight progression.
Why the study?
Does salt restriction or enalapril prevent cardiomegaly in a rat model of chronic myocardial infarction?
Does salt restriction or enalapril prevent cardiomegaly in a rat model of chronic myocardial infarction?
In a rat model of chronic myocardial infarction, ACE inhibition with enalapril prevented progressive cardiomegaly and pulmonary congestion, whereas salt restriction did not.
Answers are grounded in this paper and cite their sources.
Does not support salt restriction for post-MI cardiomegaly; animal data leave open translation of enalapril benefit to human chronic HF.
The effects of salt restriction and the ACE inhibitor enalapril were compared in a model of chronic myocardial infarction in the rat. Total exchangeable sodium was measured by an isotopic dilution technique to quantitate the effects of the low salt diet and ACE inhibitor on body sodium and extracellular fluid. Rats with infarction developed a marked increase in cardiac weight (4.29 +/- 0.18 mg/g body weight) compared with control rats (3.64 +/- 0.08 mg/g, p less than 0.01). There was hypertrophy of both left and right ventricles. Salt restricted rats with infarction developed identical cardiomegaly (4.30 +/- 0.11 mg/g), although total exchangeable body sodium fell by 10% (p less than 0.001). In contrast, rats with infarction receiving enalapril developed significantly less cardiomegaly (3.97 +/- 0.10 mg/g) while body sodium remained unchanged. Rats with infarction had a significant increase in lung weight which was not changed by salt restriction but which was abolished by enalapril. These results suggest that salt restriction does not prevent the progression of cardiomegaly in chronic left heart failure. In contrast our results confirm the ability of ACE inhibitors to prevent progressive cardiomegaly and left heart failure without affecting long-term changes in sodium balance.
No takes yet. Share an insight, caveat, or question.
Hodsman et al. (1988) studied Chronic myocardial infarction. Enalapril and salt restriction vs. Control (infarction without treatment) was evaluated on Cardiac weight (cardiomegaly). Enalapril reduced cardiomegaly in rats with chronic myocardial infarction, whereas salt restriction had no effect on cardiac weight progression.
Synapse has enriched 10 related papers. Consider them for comparative context: